20Keywords:Biochemistry,Polymer Sinthesis,Nanofiber Science,Medical Devises,Bibliometrics,Science Metrics,Computational ChemProjects:Liquid Embolic Material for Neurovascular Therapy;Angiographic MoleculesPositions and Scientific Appointments2022 -Honors2022Technology (FTST), Institute of High Polymer Research (IHPR), Synthetic Polymer Division, Ueda 386-8567, JapanDivision, Ueda 386-8567, JapanProfessor, Shinshu Univ, Interdisciplinary Cluster for Cutting Edge Research (ICCER), Institute for Fiber Engineering (IFES), Head, Division of Social ImplementationDeputy Director, Shinshu Unive, ICCER, IFESChief Technology Officer, AquaTeXMedical, Inc., Research and Development, Irvine, CA93617, USAResearch Associate, University of California, Irvine, Medical Center, Department of Neurological Surgery, Orange, CA92868, USAProfessor, Shinshu Univ, ICCER, IFES, Head, Division of Biological and Medical Fibers, Ueda 386-8567, JapanProfessor, Shinshu Univ, ICCER, IFES, Division of Biological and Medical Fibers, Ueda 386-8567, Japan2021 -2020 -2019 -2015 -2014 -2003 -2014Associate Professor, Shinshu Univ, Faculty of Textile Science and 1996 -2003Assistant Professor, Shinshu Univ, FTST, IHPR, Synthetic Polymer 20212015Audience Award: 3rdKyoto University LifeScienceShowcase at San Diego, Organizer and sponsors, Kyoto University, AMED, AIFAM group, LINK-J, JETRO, UC San Diego, Biocom California, March 2ndGrand Prize: The 1stTriple Bridge Acceleration Program Innovation Contest, AIFAM Group, LLC, August 6th.The Award, The Society of Fiber Science and Technology, JapanPublic Links (clickable):ResearchmapKAKENNCBIGoogle ScholarLinkedInMessages: IFES3.0 manages five divisions for providing "Interplays of Researches" to scholars all over the world. Division of Social Implementation (DSI) has a key role for providing the informatic and metrics on scientific or social impact by the research outcomes of IFES3.0. Very feasible, reviewed, and selected researches can be promoted as the DSI projects, realizing social implementation and business profits. Dr. Ohkawa also has been appointed as the CTO, AquaTeXMedical, Inc, a Delaware C-Corporation established in 2020, and is responsible for due diligences, intellectual properties, and regulatory process developments. He is a part of international, collaborative activities of IFES3.0, planning and executing online seminars or workshops, as the best learning practices and opportunities for graduate students and researchers at IFES3.0Division of Bibliometrics & Social Implementation?HeadKousaku Ohkawa, Ph.D.
元のページ ../index.html#21